Results 141 to 150 of about 29,707 (225)

Rituximab vs. Cyclophosphamide induction therapy for patients with ANCA-associated vasculitis. [PDF]

BMC Rheumatol
Wu W, Wang J, Chen S.
europepmc   +1 more source

Urinary complement C3 fragment levels and their clinical relevance in MPO-ANCA-associated vasculitis. [PDF]

Sci Rep
Hu Y, Shi M, Huang Q, Wan S, Zhang M, Wang Z, Huang W, Zhang S, Xiong F.   +8 more
europepmc   +1 more source

Effective Management of a Rare Case of Pediatric ANCA-Associated Vasculitis With Rituximab and Mycophenolate Mofetil. [PDF]

Am J Case Rep
Fang Y, Kurady A, Hashim FQ, Berger B, Rao A.   +4 more
europepmc   +1 more source

Challenging manifestations of ANCA-associated vasculitis treated with avacopan: two case reports. [PDF]

Front Immunol
Chalkia A, Politi A, Tryfonos I, Koutsianas C, Gakiopoulou H, Vassilopoulos D, Petras D.   +6 more
europepmc   +1 more source

Use of Avacopan as a Steroid-Sparing Medication in ANCA-associated Vasculitis Patients with Renal Impairment

Translation
Mitchell Salke, Tahrima Ferdous, Nezam Altorok   +2 more
doaj   +1 more source

Mapping a path forward: addressing disease burden, pathways and solutions in ANCA-associated vasculitis. [PDF]

Rheumatology (Oxford)
Hellmich B.
europepmc   +1 more source

Repeat kidney biopsy reveals new-onset IgA nephropathy in a patient with ANCA-associated vasculitis. [PDF]

CEN Case Rep
Iwami S, Eriguchi M, Kosugi T, Furuyama R, Kitamura S, Tanabe K, Matsui M, Samejima KI, Tsuruya K.   +8 more
europepmc   +1 more source

Early VV-ECMO enabling immunosuppressive therapy in severe diffuse alveolar hemorrhage due to ANCA-associated vasculitis. [PDF]

Respir Med Case Rep
Jung YJ, Ryu S, Kim Y, Shin KC, Jo S, Yoon SG, Kim JT.   +6 more
europepmc   +1 more source

Predicting prognosis in ANCA-associated vasculitis with kidney involvement. [PDF]

Clin Kidney J
Maalouli C, Aydin S, Collard A, Cambier JF, Dejardin A, Georges B, Gillerot G, Vanderperren B, Vandooren AK, Jadoul M, Morelle J, Demoulin N, UCLouvain Kidney Disease Network .   +12 more
europepmc   +1 more source